Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.62 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.55 |
| ▸ | MMP9 | P14780 | 1/20 | 0.55 |
| ▸ | MMP8 | P22894 | 1/20 | 0.55 |
| ▸ | MMP13 | P45452 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.51 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.48 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.48 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30586133 | 1.00 | AR (0.62) | ARCYP19A1CA1CA2MMP1 | |
| SCHEMBL29592713 | 0.79 | CA1 (0.54) | ARCYP19A1CA1CA2MMP1 | |
| SCHEMBL15318838 | 0.79 | CA1 (0.54) | ARCYP19A1CA1CA2MMP1 | |
| SCHEMBL31318363 | 0.79 | AR (0.57) | ARCYP19A1CA1CA2MMP1 | |
| SCHEMBL6535542 | 0.78 | CYP19A1 (0.58) | ARCYP19A1CA1CA2MMP1 | |
| SCHEMBL4504076 | 0.78 | CYP19A1 (0.83) | ARCYP19A1CA1CA2MMP1 | |
| SCHEMBL1630292 | 0.77 | CA1 (0.63) | CYP19A1CA1CA2MMP1MMP2 | |
| SCHEMBL29096884 | 0.77 | CYP19A1 (0.56) | ARCYP19A1CA1CA2MMP1 | |
| SCHEMBL2494822 | 0.76 | TDP1 (0.51) | CA1CA2KMT2AMEN1TDP1 | |
| SCHEMBL18455317 | 0.76 | KMT2A (0.44) | ARCA1CA2KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3854786-B1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | UBE CORP (JP) | 2026-02-18 | — | — | EP | disclosed |
| US-12281074-B2 | Method for producing amino acid derivatives | UBE CORPORATION (JP) | 2025-04-22 | — | — | US | disclosed |
| US-12202800-B2 | Method for producing amino acid derivatives | API CORPORATION (JP) | 2025-01-21 | — | — | US | disclosed |
| CN-118271319-A | Beta-lactamase inhibitor urea-containing bicyclic compound, preparation method and application thereof | 成都四面体药物研究有限公司 | 2024-07-02 | — | — | CN | disclosed |
| US-20240150292-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | API CORPORATION (JP) | 2024-05-09 | — | — | US | disclosed |
| US-11897844-B2 | Method for producing amino acid derivatives | API CORPORATION (JP) | 2024-02-13 | — | — | US | disclosed |
| US-20240002340-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | API CORPORATION (JP) | 2024-01-04 | — | — | US | disclosed |
| CN-110709081-B | Compounds and methods for treating bacterial infections | 恩塔西斯治疗公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-3766869-B1 | SIMPLE PREPARATION METHOD FOR AVIBACTAM | XINFA PHARMACEUTICAL CO LTD (CN) | 2023-05-10 | — | — | EP | disclosed |
| EP-3733648-B1 | METHOD FOR PREPARING 5R-BENZYLOXYAMINOPIPERIDIN-2S-CARBOXYLIC ACID OR DERIVATIVE THEREOF | XINFA PHARMACEUTICAL CO LTD (CN) | 2022-06-08 | — | — | EP | disclosed |
| WO-2013149136-A1 | ISOXAZOLE β-LACTAMASE INHIBITORS | CUBIST PHARMACEUTICALS, INC. (US) | 2013-10-03 | — | — | WO | disclosed |
| US-7638505-B2 | Organophosphoric derivatives useful as anti-parasitic agents | UNIVERSITEIT GENT (BE) | 2009-12-29 | — | — | US | disclosed |
| US-20080312190-A1 | Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents | UNIVERSITEIT GENT (BE) | 2008-12-18 | — | — | US | disclosed |
| EP-1963344-A1 | ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS | UNIVERSITEIT GENT (BE) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007071453-A1 | ORGANOPHOSPHORIC DERIVATIVES USEFUL AS ANTI-PARASITIC AGENTS | UNIVERSITEIT GENT (BE) | 2007-06-28 | — | — | WO | disclosed |
| EP-0023141-B1 | HERBICIDAL SULFONAMIDES, PREPARATION AND USE THEREOF, COMPOSITIONS CONTAINING THEM, INTERMEDIATES THEREFOR AND PREPARATION OF SUCH INTERMEDIATES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-04-11 | — | — | EP | disclosed |
| US-4417917-A | BENZENE DISULFONIC ACID DERIVATIVES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-11-29 | — | — | US | disclosed |
| EP-0070041-A2 | Substituted benzenesulfonyl isocyanates and isothiocyanates and processes for their preparation | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-01-19 | — | — | EP | disclosed |
| US-4310346-A | HERBICIDES AND PLANT GROWTH REGULATORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-01-12 | — | — | US | disclosed |
| EP-0023141-A2 | Herbicidal sulfonamides, preparation and use thereof, compositions containing them, intermediates therefor and preparation of such intermediates | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150292-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | PTGS2, PTGES, PTGS1 | AR 906/4885CYP19A1 392/4885CA1 3133/4885 |
| US-12202800-B2 | Method for producing amino acid derivatives | GLO1, BCAT2, BCAT1 | AR 1266/4885CYP19A1 385/4885CA1 612/4885 |
| US-20080312190-A1 | Such as 3-(N-hydroxyacetamido)-1-(3,4-dichlorophenyl)propylphosphonic acid; Antimalaria agents | SUB1, CBR1, NAT1 | AR 4420/4885CYP19A1 3949/4885CA1 1258/4885 |
| US-20240002340-A1 | METHOD FOR PRODUCING AMINO ACID DERIVATIVES | GLO1, BCAT2, BCAT1 | AR 1266/4885CYP19A1 385/4885CA1 612/4885 |
| US-11897844-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | AR 1045/4885CYP19A1 450/4885CA1 3249/4885 |
| US-12281074-B2 | Method for producing amino acid derivatives | PTGS2, PTGES, PTGES2 | AR 1045/4885CYP19A1 450/4885CA1 3249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.